Amrize (NYSE:AMRZ) Price Target Lowered to $58.00 at Wells Fargo & Company

Amrize (NYSE:AMRZ) had its price objective decreased by equities research analysts at Wells Fargo & Company from $65.00 to $58.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price would suggest a potential upside of 15.05% from the stock’s current price.

AMRZ has been the topic of several other reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Amrize in a research note on Friday, June 26th. Truist Financial reissued a “hold” rating and issued a $48.00 price objective (down from $65.00) on shares of Amrize in a report on Tuesday. Royal Bank Of Canada lowered their price objective on Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research note on Friday, May 1st. Morgan Stanley set a $63.00 target price on shares of Amrize and gave the stock an “overweight” rating in a research report on Monday, June 22nd. Finally, Oppenheimer set a $68.00 price target on shares of Amrize in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Amrize currently has an average rating of “Moderate Buy” and a consensus price target of $63.00.

Amrize Price Performance

Shares of AMRZ opened at $50.41 on Wednesday. The stock has a market cap of $27.88 billion and a P/E ratio of 23.94. The business’s fifty day moving average is $53.09 and its 200 day moving average is $55.60. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. Amrize has a 12-month low of $44.12 and a 12-month high of $65.94.

Amrize (NYSE:AMRZ) last issued its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The company had revenue of $2.18 billion for the quarter. The company’s revenue was up 4.7% compared to the same quarter last year. Sell-side analysts anticipate that Amrize will post 2.75 earnings per share for the current fiscal year.

Insider Activity at Amrize

In other news, insider Mario Gross purchased 2,800 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The stock was acquired at an average cost of $49.17 per share, for a total transaction of $137,676.00. Following the completion of the purchase, the insider owned 33,747 shares of the company’s stock, valued at approximately $1,659,339.99. This trade represents a 9.05% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jan Philipp Jenisch acquired 21,417 shares of the business’s stock in a transaction on Friday, May 15th. The shares were purchased at an average price of $49.67 per share, for a total transaction of $1,063,782.39. Following the purchase, the chief executive officer directly owned 1,724,999 shares of the company’s stock, valued at $85,680,700.33. This represents a 1.26% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders acquired 54,920 shares of company stock worth $2,717,429. 0.54% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Amrize

Several large investors have recently added to or reduced their stakes in the company. DMKC Advisory Services LLC boosted its holdings in shares of Amrize by 11.9% during the second quarter. DMKC Advisory Services LLC now owns 67,832 shares of the company’s stock worth $3,615,000 after acquiring an additional 7,223 shares during the period. Grove Bank & Trust lifted its stake in Amrize by 5.6% during the 2nd quarter. Grove Bank & Trust now owns 17,124 shares of the company’s stock valued at $913,000 after acquiring an additional 906 shares in the last quarter. Glenmede Trust Co. NA purchased a new position in shares of Amrize in the 1st quarter worth approximately $270,000. Janus Henderson Group PLC grew its stake in Amrize by 9.5% in the 1st quarter. Janus Henderson Group PLC now owns 36,878 shares of the company’s stock valued at $2,066,000 after purchasing an additional 3,200 shares during the period. Finally, Amundi grew its stake in Amrize by 30.9% in the 1st quarter. Amundi now owns 1,654,739 shares of the company’s stock valued at $92,698,000 after purchasing an additional 390,750 shares during the period.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.